• Tidak ada hasil yang ditemukan

Comparison of sumatriptan and propofol VS Sumatriptan and placebo in acute migraine

N/A
N/A
Protected

Academic year: 2023

Membagikan "Comparison of sumatriptan and propofol VS Sumatriptan and placebo in acute migraine"

Copied!
4
0
0

Teks penuh

(1)

1

Clinical Trial Protocol

Iranian Registry of Clinical Trials

05 Nov 2022

Comparison of sumatriptan and propofol VS Sumatriptan and placebo in acute migraine

Protocol summary

Summary

In this double-blinded, randomized trial, we compare the efficacy of combination of subcutaneus Sumatriptan and Propofol VS subcutaneus Sumatriptan and placebo for treatment of acute migraine. A total of 60 cases of acute migraine attack aged between 15 and 45 years admitted to the emergency department will be randomly divided into two treatment groups: (1) 6 mg of Sumatriptan subcutaneously and 30 µg.kg.min of Propofol infused intravenously, (2) 6 mg of Sumatriptan subcutaneously and placebo. Headache severity will be assessed use a visual analog scale before treatment, 0.5 and 1 hour after treatment. Accompanying symptoms, probable side effects will be also assessed. Follow-up was conducted 72 hours later by calling the patients and inquiring about headache recurrence.

General information

Acronym

IRCT registration information

IRCT registration number: IRCT2015050422089N1 Registration date: 2016-01-29, 1394/11/09 Registration timing: retrospective

Last update:

Update count: 0 Registration date

2016-01-29, 1394/11/09 Registrant information

Name

Reza Farahmand Rad

Name of organization / entity

Kermanshah university of Medical Science Country

Iran (Islamic Republic of) Phone

+98 21 2298 9356 Email address

rfarahmandrad@ssu.ac.ir Recruitment status

Recruitment complete Funding source

Vice chancellor for research, Shahid Sadoughi University of Medical Science of Yazd

Expected recruitment start date 2014-09-21, 1393/06/30

Expected recruitment end date 2015-09-21, 1394/06/30 Actual recruitment start date

empty

Actual recruitment end date empty

Trial completion date empty

Scientific title

Comparison of sumatriptan and propofol VS Sumatriptan and placebo in acute migraine

Public title

Comparison of sumatriptan and propofol VS Sumatriptan and placebo in acute migraine

Purpose Treatment

Inclusion/Exclusion criteria

Inclusion criteria: all patient aged 18 to 45 years old with migrain headache Exclusion criteria: Pregnancy,

Hypertension, Previous CVA, propofol sensitivity, Sumatriptan sensitivity, coronary artery disease.

Age

No age limit Gender

Both Phase

Bioequivalence

(2)

2 Groups that have been masked

No information Sample size

Target sample size: 60

Randomization (investigator's opinion) Randomized

Randomization description Blinding (investigator's opinion)

Double blinded Blinding description Placebo

Used Assignment

Parallel

Other design features

Secondary Ids

1

Registry name -

Secondary trial Id -

Registration date empty

Ethics committees

1

Ethics committee

Name of ethics committee

Ethics committee of Shahid Sadoughi University of Medical Science

Street address

Shahid Sadoughi University of Medical Science, Bahonar square, Yazd, Iran

City Yazd Postal code Approval date

2015-02-03, 1393/11/14

Ethics committee reference number 17/1/235385

Health conditions studied

1

Description of health condition studied Migraine

ICD-10 code G43.2-G43.

ICD-10 code description

Migraine without aura (common migraine )

Primary outcomes

1

Description Pain Timepoint

Before intervention, 10-minute iterval after intervention until 1 hour

Method of measurement Visual pain score

Secondary outcomes

1

Description Hypoxia Timepoint

Before intervention, 10- minute interval after intervention until 1 hour

Method of measurement Pulse oximetry

Intervention groups

1

Description

In intervention group after starting IV Line 30

microgram/kg/ Propofol in 100cc normal saline infused for one hour and 6 miligram Sumatriptane injected subcutaneously .

Category

Treatment - Drugs

2

Description

In control group after starting IV line100 cc normal saline as placebo infused for one hour and 6 miligram

Sumatriptane injected subcutaneousely.

Category

Treatment - Drugs

Recruitment centers

1

Recruitment center

Name of recruitment center Shahid Sadoughi hospital Full name of responsible person

Dr. Reza Farahmand Rad- Dr. Marzieh Ghilian Street address

Ebne sina street, Shahid ghandi boulevard, Safaieh City

Yazd

2

Recruitment center

Name of recruitment center Shahid Rahnemoon hospital

(3)

3 Full name of responsible person

Dr. Reza Farahmand Rad- Dr. Marzieh Ghilian Street address

Farrokhi street, Shahid Rahnemoon hospital City

Yazd

Sponsors / Funding sources

1 Sponsor

Name of organization / entity

Vice chancellor for research, Shahid Sadoughi university of Medical Science Of Yazd

Full name of responsible person Dr. Hushang Mehrparvar Street address

Central department of Shahid Sadoughi university of Medical Science, Bahonar square, Yazd, Iran

City Yazd Grant name

Grant code / Reference number

Is the source of funding the same sponsor organization/entity?

Yes

Title of funding source

Vice chancellor for research, Shahid Sadoughi university of Medical Science Of Yazd

Proportion provided by this source 100

Public or private sector empty

Domestic or foreign origin empty

Category of foreign source of funding empty

Country of origin

Type of organization providing the funding empty

Person responsible for general inquiries

Contact

Name of organization / entity

Shahid Sadoughi University of Medical Science Full name of responsible person

Dr. Marzieh Ghilian Position

Emergency Medicine Resident Other areas of specialty/work Street address

Emergency Department, Shahid Sadoughi hospital City

Yazd Postal code Phone

+98 358223511 Fax

Email

marziehghilian@yahoo.com / ghilian@ssu.ac.ir

Web page address

Person responsible for scientific inquiries

Contact

Name of organization / entity

Shahid Sadoughi University of Medical Science Full name of responsible person

Dr. Reza Farahmand Rad Position

Assistant Professor of Emergency Medicine Other areas of specialty/work

Street address

Emergency Department, Shahid Sadoughi hospital City

Yazd Postal code Phone

+98 35 3822 3514 Fax

Email

rfarahmandrad@ssu.ac.irrfarahmandrad@gmail.com Web page address

Person responsible for updating data

Contact

Name of organization / entity

Shahid Sadoughi University of Medical Science Full name of responsible person

Dr. Reza Farahmand Rad Position

Assistant Professor of Emergency Medicine Other areas of specialty/work

Street address

emergency department shahid sadoughi hospital City

yazd Postal code Phone

00 Fax Email

rfarahmandrad@ssu.ac.ir rfarahmandrad@gmail.com Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD) empty

Study Protocol empty

Statistical Analysis Plan empty

Informed Consent Form empty

Clinical Study Report empty

Analytic Code empty Data Dictionary

(4)

4 empty

Referensi

Dokumen terkait

General information Acronym IRCT registration information IRCT registration number: IRCT138810112950N1 Registration date: 2010-04-14, 1389/01/25 Registration timing: retrospective